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1An increase in pulse pressure after middle age, more marked in women than in men, leading to an increase 
in systolic blood pressure (BP) is the major cause of incident 
hypertension in the aging population.1 Systolic BP and pulse 
pressure are also the BP components most closely associated 
with cardiovascular risk because of hypertension in mid-
dle-aged to older subjects.2 Central pulse pressure (cPP), has 
been thought to be mainly determined by stiffness of the aorta, 
with age-related aortic stiffening leading to an irreversible in-
crease in cPP.3 However, cPP is also influenced by left ventric-
ular ejection dynamics and by pressure wave reflection.4,5 cPP 
can be partitioned into a component related to the first shoulder 
(P1) of the pressure waveform and subsequent augmentation 
pressure (AP), leading to the second peak (with pulse pressure 
P2) usually equal to cPP (Figure 1). Although AP is usually 
only a small fraction of cPP, an increase in AP plays a dispro-
portionate contribution to the age-related increase in cPP.6,7 
Previously attributed to pressure wave reflection,8 studies 
from Framingham have shown that reflection (when assessed 
as the amplitude of backward to forward pressure wave am-
plitude) contributes to a minor degree to age-related changes 
in cPP and AP.7,9 By contrast, recent studies have highlighted 
the potential importance of ventricular ejection dynamics in 
determining pulsatile pressure components.5,9,10 Theoretical 
principles supported by in-silico simulations and experimental 
data suggest that, to a first approximation, P1 is determined 
by the product of proximal aortic pulse wave velocity (PWV) 
and aortic flow velocity (U1) at the time of P1,11 and P2 by 
the product of aortic PWV and ejection volume at the time of 
P2 (V2).12 Assuming proportionality of proximal/distal aortic 
PWV and of left ventricular outflow/aortic cross-sectional 
areas, the ratio P2/P1 (closely related to augmentation index) 
is then simply determined by the ratio of V2/U1 (Figure 1).
The aim of the present study was thus to examine whether 
age-related changes in central pressure components in the Twins 
UK cohort, a cohort of female twins representative of women in 
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of central pulse pressure were compared with values predicted from aortic pulse wave velocity and ventricular ejection 
characteristics. Central pulse pressure at the first shoulder (P1) increased with age from 29.2±8.0 in those <40 years to 
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increase in aortic pulse wave velocity. Pulse pressure, at the second pressure peak (P2, usually equal to peak central pulse 
pressure) increased to a greater extent with age: from 29.1±7.8 mm Hg for those <40 years to 60.2±20.5 mm Hg for those 
>70 years (P<0.001). The ratio of P2/P1 closely mirrored the ratio of ejection volume to ejection velocity at corresponding time 
points, and the proportionately greater increase in P2 compared with P1 was explained by increased ventricular ejection 
up to the time of P2. This increased from 52.5±13.1 to 59.3±17.8 mL (P<0.001) in parallel with an age-related increase in 
stroke volume and body mass index. These results suggest that the age-related change in central pulse wave morphology is 
driven mainly by an increase in arterial stiffening and altered pattern of ventricular ejection.  (Hypertension. 2019;73:00-
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the general population in the UK, can be explained by a combi-
nation of arterial stiffening (increase in PWV) and age-related 
change in ventricular ejection dynamics. We measured cen-
tral aortic pressure by carotid tonometry and aortic flow using 
pulsed wave Doppler ultrasound. Ventricular ejection volumes 
were obtained by integration of aortic flow and, in a sub-sample, 
estimated from 2D echocardiograms. cPP was divided into com-
ponents related to P1 and AP. Wave intensity analysis and wave 
separation analysis was used to examine the contribution of for-
ward and backward pressure waves to these components.
Methods
Study Population
Subjects comprised 2033 unselected female twins from the Twins 
UK cohort. Most of the measurements are available for external 
researchers to use via application to Twins UK: http://twinsuk.ac.uk. 
The study was approved by the St Thomas’ Hospital Research Ethics 
Committee, and written informed consent was obtained from all sub-
jects. Measurements were performed during a single visit to a quiet 
temperature-controlled vascular laboratory (22°C–24°C) over the pe-
riod 2006 to 2016. Height and weight were measured and smoking 
status, menopausal status, and medication use recorded. Fasting total 
cholesterol, high-density lipoprotein cholesterol, triglycerides, and 
glucose were measured in an accredited laboratory.
Hemodynamic Measurements
Hemodynamic measurements were performed as previously 
described.5 Radial and carotid pressure waveforms were obtained by 
applanation tonometry performed by an experienced operator using 
the SphygmoCor system (AtCor, Australia). Approximately 10 car-
diac cycles were ensemble averaged. Waveforms that did not meet 
the in-built quality control criteria in the SphygmoCor system were 
rejected. Brachial BP was measured in triplicate by a validated oscil-
lometric method (Omron 705CP, Omron Health Care, Japan) immedi-
ately before measurements of tonometry and used to calibrate radial 
waveforms and thus to obtain a mean arterial pressure through integra-
tion of the radial waveform. Carotid waveforms were calibrated from 
mean arterial pressure and diastolic brachial BP on the assumption of 
equality of these pressures at central and peripheral sites.13 Carotid-
femoral PWV was calculated from sequential recordings of the carotid 
and femoral artery pressure waveforms using the same SphygmoCor 
device and transducer. Difference in time of pulse arrival between the 
2 sites referenced to the R wave of the ECG was taken as the transit 
time. Path length between these 2 sites was estimated from the distance 
between the sternal notch and femoral artery at the point of applanation 
and PWV calculated as the quotient of path length and transit time. 
Measurements were made in triplicate, and mean values were used for 
analysis. Ultrasound imaging was performed by an experienced oper-
ator using a Siemens CV70 ultrasound system (Acuson-Siemens Corp, 
California) before 2010 and later Vivid-7 ultrasound platform (General 
Electric Healthcare, UK). Flow velocity in the left ventricular outflow 
tract (LVOT) was recorded using pulsed wave Doppler obtained from 
an apical 5-chamber view. All ultrasound measurements were averaged 
over at least 3 cardiac cycles. Ultrasound measurements were obtained 
immediately after measurements of BP and tonometry.
Waveform Postprocessing
Ensemble-averaged carotid pressure was used as surrogate for as-
cending aortic pressure.14 This together with LVOT flow velocity 
was processed offline using custom software written in MATLAB 
(MathWorks, Natick). The first systolic shoulder/peak of the aortic 
pressure waveform was identified as the first local minimum of the first 
derivative of the pressure curve (and confirmed by visual inspection by 
an observer blinded to the results) to determine P1 and AP as the dif-
ference between pulsatile pressure at the second systolic peak (P2) 
and that at P1. Augmentation index was calculated as: AP/cPP×100%. 
LVOT flow velocity was multiplied by LVOT cross-sectional area to 
obtain the aortic flow. Ejection volumes (V1 and V2) corresponding to 
timing of P1 and P2 (T1 and T2) were obtained by integration of the 
aortic flow waveform from the start of systole to T1 and T2. Stroke 
volume (SV) was obtained by integration of aortic flow waveform, 
and cardiac output (CO) as the product of SV and heart rate. In a 
sub-sample of subjects, SV was also obtained as the difference be-
tween left ventricular end-systolic volume and end-diastolic volume. 
End-diastolic volume and end-systolic volume were calculated using 
the formula of Teichholz: V
D
D=
+
7
2 4
3
.
, where D is the maximum 
minor axis of the left ventricle at end-diastole or end-systole and was 
measured on the parasternal long-axis or short-axis view.15
Pressure wave decomposition was performed using Parker’s 
time-domain approach,16 based on conservation of mass and momen-
tum, to obtain forward (Pf) and backward (Pb) pressure components 
of cPP so that: Pf+Pb=P–Pd, where P is total pressure and Pd is the 
Figure 1. Relation of central pulse pressure 
components to ejection flow and volume. A, 
Central pressure waveform showing the first 
systolic shoulder (P1) and second peak (P2) 
which is usually equal to central pulse pressure 
(cPP). Augmentation pressure (AP) is the 
difference between P2 and P1. B, Aortic flow 
velocity (U) and ventricular ejection volume (V) 
obtained by integration of flow velocity and 
multiplication by cross-sectional area. C, P1 is 
proportional to the product of aortic pulse wave 
velocity (PWV) with aortic flow velocity at time 
of P1 (U1) and P2 to the product of PWV and 
ejection volume at time of P2 (V2). Thus the 
P2/P1 ratio is predicted to depend only on the 
characteristics of ventricular ejection defining 
V2/U1. D, Relationship of P2/P1 to V2/U1 in 
Twins UK.
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diastolic pressure. Pf and Pb are given by: P dP cdUf = ∑ +( )12 [ ]ρ  
and P dP cdUb = ∑ −( )12 [ ]ρ
Where U is flow velocity, ρ is blood density, and c is PWV which 
was calculated using the method of the sum-of-squares (PWVss).17 
LVOT velocity rather than true aortic flow velocity (which may differ 
from LVOT velocity because of the change in cross-sectional from 
LVOT to aorta) was used to calculate both PWVss and Pf and Pb be-
cause wave separation is not affected by scaling of velocity (as er-
rors in c and dU in the above equations). Wave intensity, the flux of 
wave energy per unit area, was calculated as dI=dPdU (again using 
LVOT velocity) and separated into forward (dIf) and backward (dIb) 
components: dI
c
dP cdUf b, ( )= ±
1
4
2
ρ
ρ
Wave intensity is positive for forward waves and negative for 
those that are traveling in the backward direction. Total wave energy 
can be obtained by integrating the above equation with respect to time.
Statistics
Subject characteristics and results are presented as means±SD. 
Subjects were subdivided into groups according to decades of age and 
those <40 years and >70 years. Comparisons of subject characteris-
tics across groups were made by one-way ANOVA or (for categorical 
variables) by χ2 test. Multiple regression analysis was used to analyze 
the relationship between SV, age and BMI and to examine the rela-
tionship between aortic flow, ejection volume, and PWV, since pre-
vious work has shown that pulse pressure components up to the time 
of peak flow are explained almost completely by these variables.11 
Analysis was performed using SPSS version 22 (SPSS Inc, Chicago, 
Illinois) and P<0.05 was taken as significant.
Results
Age-Related Change in PWV and Pulse Pressure 
Components
Characteristics of the study participants and peripheral BPs 
are presented in Table 1. The women were aged 18 to 91 years, 
with a mean age of 57 years; 381 (18.7%) were on treatment 
with antihypertensive drugs, and 246 (12.1%) were on lipid-
lowering treatment. Peripheral BP increased with age with a 
small increase in diastolic BP of 5.3±11.1 mm Hg across the 
age range <40 to >70 years and a greater increase in periph-
eral systolic BP of 26.2±20.6 mm Hg, corresponding to an 
increase in peripheral PP of 20.9±15.6 mm Hg. Changes in 
PWV and cPP components are summarized by decades of age 
in Table 2 and in Figure 2. Carotid-femoral PWV increased 
≈1.09±0.09 m/s per decade of aging (12.4%; P<0.001, Table2, 
Figure 2B) and proximal aortic PWV calculated by the sum-
of-squares method increased in parallel with carotid-femoral 
PWV (Table 2). In all age groups mean values of P2 were 
>P1 so that mean values of cPP were close to those of P2. P1 
and P2 increased approximately linearly across the age range 
(Figures 2A and 2B) in parallel with PWV but there was a 
greater increase in P2 (31.1±21.5 mm Hg) compared with P1 
(15.0±15.3 mm Hg), corresponding to an increase in AP and 
augmentation index of 16.0±12.2 mm Hg and 25.4±19.3 %, 
respectively over the age range. End-systolic pressure (Pes) 
increased by 17.2±13.5 mm Hg over the age range.
SV, CO, and Peripheral Vascular Resistance
There was an increase in SV of 14.3±21.9 mL (23%), over 
the age range <40 to 50–60 (Table 2) that was related to 
the increase in BMI across this age range (Figure 3, Table 
S1 in the online-only Data Supplement). In the sub-sample 
(n=1371) in whom SV was calculated from the difference be-
tween LV end-diastolic and end-systolic diameters, there was 
a difference between the absolute values of SV calculated 
by integration of the LVOT flow waveform and LV dimen-
sions. However, the relationship between SV and BMI did 
not differ according to the method for measuring SV and the 
Table 1. Subject Characteristics
Measurements
Age, y
P Value<40 (n=245) 40–50 (n=286) 50–60 (n=534) 60–70 (n=665) >70 (n=303)
Age, y 30±6 45±3 55±3 64±3 75±4 <0.001
Height, cm 164.9±6.0 162.9±6.3 162.9±6.4 161.4±5.8 159.6±5.9 <0.001
Weight, kg 62.6±10.7 65.9±11.9 69.2±13.1 66.8±11.7 66.5±10.2 <0.001
BMI, kg/m2 23.0±3.9 24.8±4.1 26.1±4.7 25.6±4.3 25.7±4.0 <0.001
Smoker, % 16.8 12.6 7.30 5.86 3.96 <0.001
Diabetes mellitus, % 0.4 1.05 1.67 2.41 2.64 <0.001
Antihyperten, % 2.04 5.24 13.5 24.4 41.9 <0.001
Statin, % 0.4 1.40 7.49 17.0 29.0 <0.001
SBP, mm Hg 110.6±9.9 116.0±13.7 123.3±15.1 129.4±16.7 136.8±18.8 <0.001
DBP, mm Hg 69.3±7.8 72.8±9.1 75.2±8.7 75.2±8.6 74.6±8.8 <0.001
Total cholesterol, mmol/L 4.71±0.77 5.14±0.82 5.61±0.97 5.82±1.1 5.49±1.0 <0.001
LDL, mmol/L 2.75±0.80 3.21±0.86 3.54±0.94 3.69±1.1 3.35±1.0 <0.001
HDL, mmol/L 1.94±0.49 1.86±0.44 1.94±0.49 2.00±0.52 2.07±0.52 <0.001
TG, mmol/L 0.76±0.34 0.90±0.57 0.99±0.50 1.06±0.48 1.06±0.51 <0.001
Antihyperten indicates antihypertensive therapy; BMI, body mass index; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; 
SBP, peripheral systolic blood pressure; and TG, triglycerides.
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percentage change with age and BMI was similar irrespective 
of whether SV was derived from flow velocity or LV volumes, 
with SV increasing across the range of BMI <25 to >30 by 
8.9% and 9.6% as derived by flow velocity and LV volumes, 
respectively (supplementary Table S1) and the association 
of SV with BMI when adjusted for age was similar for both 
methods (standardized β coefficients of 0.13 and 0.15 for 
SV derived from LVOT flow and LV volumes, respectively). 
The increase in SV, corresponded to an increase in CO of 
0.8 L/min over the total age range (but again limited mainly to 
the range <40 to 50–60) which accounted for the increase in 
mean arterial pressure of 13.9 mm Hg over the total age range 
with systemic vascular resistance remaining constant over the 
total age range (P=0.177).
Characteristics of the Aortic Flow Waveform
Flow waveform characteristics are presented in Table 3 and 
Figure S1. LVOT maximum flow velocity (Umax) and mean 
flow velocity (Umean) both increased with age (by 0.06 and 
0.04 m/s respectively, each P<0.005) as did the duration of 
systole, largely accounting for the increase in SV across the 
age range. Both T1 and T2 decreased slightly with age. U1 
decreased slightly with age but U2 increased with age, and 
the same trends were seen with ejection volumes V1 and V2. 
Thus in addition to greater V2 and SV in older subjects, there 
was an age-related change in the pattern of ejection, with a 
greater proportion of ejected volume occurring later in sys-
tole (Table 3).
Wave Intensity Analysis
The amplitudes of forward and backward pressure waves and 
of values of individual forward and backward components of 
pressure (P1, P2, and Pes) and timings of these are shown in 
supplementary Table S2. Wave intensities and timing of wave 
intensity components are shown in supplementary Table S3. 
P1 and P2 were determined mainly by the forward wave 
across the age range (Table S2). The backward wave provided 
a proportionately greater contribution to P2 and Pes than to 
P1, and this contribution increased across the age range with 
the contribution of the backward wave to P2 increasing from 
6.5±3.5 mm Hg in those <40 years to 13.5±6.8 mm Hg in those 
>70 years group (P<0.001). The ratio of the backward wave 
component to the forward wave component of pulse pressure 
remained approximately constant (Figure S1) although the re-
flection coefficient (ratio of maximum amplitude of backward 
to forward wave) tended to increase and then decrease with 
age (Table S2). The forward wave comprised mainly a forward 
compression wave with a relatively minor contribution from 
a forward expansion wave whereas compression and expan-
sion components of the backward wave were of approximately 
equal magnitude (Table S3). The peak of the forward wave was 
delayed in systole with increasing age. However, this was due 
to delay of the expansion wave since the forward compres-
sion wave tended to arrive earlier in systole in older compared 
with younger subjects (Table S3). The backward wave arrived 
earlier in subjects >70 years compared with those <40 years 
(104±44 versus 86±34 ms; P<0.001). Both compression and 
Table 2. Central Hemodynamics
Measurement
Age, y
P Value<40 (n=245) 40–50 (n=286) 50–60 (n=534) 60–70 (n=665) >70 (n=303)
Central pressures
cSBP, mm Hg 100.0±0.80 109.5±0.99 120.5±0.88 126.5±0.82 135.2±1.4 <0.001
PP, mm Hg 31.5±0.57 37.5±0.66 45.5±0.60 51.7±0.67 60.4±1.2 <0.001
P1, mm Hg 29.2±0.54 30.5±0.47 33.7±0.40 37.9±0.45 44.2±0.79 <0.001
P2, mm Hg 29.1±0.52 37.1±0.67 45.4±0.60 51.4±0.67 60.2±1.2 <0.001
Pes, mm Hg 19.4±0.37 24.7±0.44 29.5±0.40 32.7±0.41 36.6±0.73 <0.001
AP, mm Hg −0.1±0.43 6.62±0.39 11.7±0.33 13.5±0.37 15.9±0.63 <0.001
AIx, % −0.33±1.1 16.0±0.82 24.2±0.48 24.8±0.51 25.0±0.73 <0.001
Pulse wave velocity
PWVss, m/s 3.27±0.07 3.43±0.06 4.06±0.06 4.66±0.07 5.42±0.13 <0.001
PWVcf, m/s 7.14±0.07 7.96±0.06 8.74±0.06 9.92±0.07 11.5±0.15 <0.001
Cardiac output and peripheral vascular resistance
SV, mL 61.6±1.07 72.5±1.17 75.9±0.81 74.5±0.77 76.5±1.37 <0.001
HR, bpm 65±0.7 61±0.6 60±0.4 62±0.4 63±0.6 <0.001
CO, L/min 3.96±0.07 4.39±0.07 4.52±0.05 4.57±0.05 4.78±0.09 <0.001
MAP, mm Hg 82.2±0.59 88.1±0.68 93.7±0.49 96.0±0.47 98.9±0.77 <0.001
SVR, mm Hg∙min/mL 20.8±0.44 20.1±0.36 20.7±0.28 21.0±0.29 20.7±0.51 0.177
Results are presented as mean±SE. AIx indicates augmentation index; AP, augmentation pressure; CO, cardiac output; cSBP, central systolic blood 
pressure; HR, heart rate; MAP, mean arterial blood pressure; P1, blood pressure at the first systolic shoulder; P2, blood pressure at the second systolic 
shoulder; Pes, end-systolic blood pressure; PP, central pulse pressure; PWVcf, carotid-femoral pulse wave velocity; PWVss, pulse wave velocity by 
sum-of-squares; SV, stroke volume; and SVR, systemic vascular resistance. 
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expansion components of the backward wave arrived earlier in 
older compared with younger subjects (Table S3).
Determinants of cPP
In multiple regression analysis, investigating flow velocity, 
ejection volume, and carotid-femoral PWV as potential deter-
minants of pressure, P1 was independently correlated to PWV 
and U1 (standardized, β 0.47 and 0.04 respectively, P<0.001 and 
P=0.030, respectively on backward stepwise regression incor-
porating PWV, U1 and V1 as potential explanatory variables, 
Table S4) but not with V1. P2 was independently correlated with 
PWV and V2 (standardized β 0.49 and 0.13 respectively, each 
P<0.001) but not with U2. Findings were similar when the anal-
ysis was restricted to subjects untreated with antihypertensive 
drugs (β=0.44 and 0.05 for relationships of P1 with PWV and 
U1 respectively, P<0.001 and P=0.021 respectively, and β=0.49 
and 0.14 for relationships of P2 with PWV and V2 respectively, 
each P<0.001). The ratio of P2/P1 was thus correlated with 
the morphology of the flow waveform V2/U1, and age-related 
changes in P2/P1 mirrored those in V2/U1 (Figure 1D).
Discussion
Understanding the hemodynamic basis of the age-related in-
crease in pulse pressure is key to targeting appropriate treatment 
strategies to prevent and treat the large burden of cardiovascular 
disease associated with hypertension in middle-aged to older 
persons. The present study confirms previous observations of 
an age-related increase in cPP with a substantial component of 
this due to an increase in AP.6,7 It also confirms previous find-
ings that the increase in augmentation index is not explained by 
an earlier arrival or increased amplitude of the backward wave 
relative to that of the forward wave, as evidenced by the reflec-
tion coefficient changing little with age and the contribution of 
the backward wave to components of pulse pressure remaining 
approximately proportional to that of the forward wave. AP can 
be influenced by ventricular dynamics, and an alternative expla-
nation for the age-related increase in AP is an altered pattern of 
ventricular ejection. The novel findings of the present study are 
that the increase in AP with age is best explained by the ratio of 
ventricular ejection volume V2 to ejection velocity U1. Although 
examining associations cannot determine causality, these asso-
ciations together with previous work support the conclusion that 
V2/U1 is a major determinant of AP. U1 falls slightly with age 
but V2 increases with age/BMI. Our results suggest, therefore, 
that the age-related increase in cPP is predominantly driven by 
an increase in PWV, which accounts for almost all of the increase 
in P1. The increase of P2 above P1 is determined by increased 
ejection volume, V2, at the time of P2 associated with a change 
in the pattern of ejection with a greater proportion of ejected 
volume occurring after T1 in older subjects. We have previously 
observed a shift towards a later sustained ventricular ejection as-
sociated with delayed relaxation of the ventricle in patients with 
hypertension. This can be explained by a reduction in first-phase 
ejection fraction, with ejection sustained to maintain overall 
ejection fraction and SV, through a reverse of the shortening-
deactivation phenomenon.18
 This mechanism could contribute 
to the altered pattern of ventricular emptying we observed in 
present study, and it is notable that the delay of the forward ex-
pansion wave driven by ventricular braking would be consistent 
with this effect. Delayed ventricular ejection could result from a 
primary cardiac phenomenon or be secondary to an increase in 
dynamic afterload characterized by increased aortic PWV. Such 
a delay in ventricular ejection would not, however, be expected 
to account for the increase in overall SV and it is more likely 
that this was driven mainly by increased BMI. The age-related 
increase in V2, was closely related to that in overall SV and 
occurred up to the age of 60 years in parallel with an increase 
in BMI, which tended to plateau after this age, as observed in 
other population studies.19 We demonstrated an independent re-
lationship of SV with BMI that is well established and thought 
to be because of the need for CO to meet metabolic demands20,21 
and thus it is likely that an age-related increase in BMI is a de-
terminant of that in V2 and overall SV. However, conclusions 
regarding causality cannot be inferred from this cross-sectional 
Figure 2. Variation of central pressure and pulse pressure components 
with age. A, Average central pressure waveforms for age groups <40 to 
>70 y. B, Relationship of central pulse pressure at first shoulder/peak (P1), 
second peak (P2), and carotid-femoral pulse wave velocity (PWV) to age.
Figure 3. Relationship of stroke volume (SV), ejection volume at time of 
second pressure peak (V2), and body mass index to age. BMI indicates 
body mass index.
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study and interventional studies will be required to examine the 
relative influence of BMI on cPP components.
Our study is subject to a number of important limitations, 
we studied only female twins from the Twins UK cohort and 
although these are representative of the general female popula-
tion in the UK, the extent to which the present findings apply in 
men requires evaluation in other cohorts. Our study is focused 
on central rather than peripheral pulse pressure because of its 
close relationship to central hemodynamics and left ventricular 
dynamic load and because it is a determinant of peripheral BP. 
Central pressure is at least as closely related to adverse outcomes 
as peripheral pressure22 and, in older subjects, differences be-
tween central and peripheral pressure are relatively modest.23 
Measurements of pressure and flow were obtained noninva-
sively, were not simultaneous and both direct measurements and 
derived measurements are inevitably subject to experimental 
error. Such errors are, however, likely to be random and un-
likely to influence relationships with age. Calibration of central 
BP from peripheral BP is known to be subject to error, and the 
method used in the present study (widely used when the study 
was designed) causes an under-estimation of central pressure 
because of brachial-radial amplification. However the relation-
ship of P2 to P1 is not affected by calibration. Measurements of 
LVOT velocity and calculation of aortic flow are subject to error 
but the finding of similar trends with age when SV was obtained 
from flow and from ventricular dimensions suggests that such 
error would have been unlikely to influence relationships with 
age. Aortic flow velocity (but not flow) differs from LVOT ve-
locity because of the change in cross-sectional area from LVOT 
to aorta but provided that the same velocity is used to calculate 
PWVss and wave separation this does not affect values or tim-
ings of forward and backward pressure waves. It does have an 
influence on wave intensity but wave intensity did not inform our 
major conclusions. Finally, it should be stressed that relation-
ships between pulsatile central pressure components, aortic stiff-
ness, and ventricular ejection dynamics will depend on the serial 
distribution of PWV and diameter along the aortic tree since P1 
is dependent on proximal aortic PWV and P2 on the compliance 
associated with the elasticity and diameter of the aorta and prox-
imal arterial tree and that the latter is incompletely captured by 
PWV.12 More detailed measurements of regional aortic structure 
and function that are possible with ultrasound will be required to 
fully characterize the relationship between pulsatile components 
of pressure and aortic structure and function.
Perspectives
The present study confirms the importance of aortic stiffening 
in contributing to increased pulsatility of central BP, par-
ticularly early in systole. In addition to arterial properties it 
identifies ventricular dynamics as a key determinant of the re-
lation between early and late systolic pulsatile components of 
pressure. Conditions and drugs that influence cardiac function 
may, therefore, influence pulse wave morphology independent 
of arterial function. SV is an important determinant of cPP, 
and the increase in cPP can be explained by an increase in 
SV occurring in parallel with that of BMI. Interventions to 
decrease SV (eg, weight reduction) and modulate ventricular 
dynamics might be useful in addition to reducing aortic stiff-
ness in preventing/treating systolic hypertension.
Conclusions
This population study in the Twins UK cohort suggests that, in 
middle-aged to older women, the age-related increase in cPP 
results from an increase in aortic stiffness, sustained ventricular 
ejection and an increase in SV that parallels that in BMI. The 
age-related change in morphology of the central pressure wave-
form, in particular the increase in the AP, relates to sustained 
ventricular ejection and an altered pattern of ventricular ejection.
Sources of Funding
This work was funded by the British Heart Foundation (special 
project grant SP/12/4/29573, project grant PG/17/50/32903), 
Table 3. Flow Waveform Characteristics
Measurement
Age, y
P Value<40 (n=245) 40–50 (n=286) 50–60 (n=534) 60–70 (n=665) >70 (n=303)
Umax, m/s 1.11±0.010 1.15±0.009 1.14±0.007 1.13±0.007 1.17±0.013 0.003
Umean, m/s 0.29±0.004 0.30±0.004 0.29±0.003 0.31±0.003 0.33±0.005 <0.001
T1, ms 103±0.9 96±0.7 92±0.5 92±0.7 92±0.9 <0.001
T2, ms 225±1.4 225±1.5 227±1.0 225±1.0 220±1.4 0.001
Tes, ms 321±1.2 331±1.2 340±0.9 339±0.9 342±1.5 <0.001
U1, m/s 1.02±0.012 1.05±0.012 1.00±0.009 0.98±0.009 0.98±0.016 <0.001
U2, m/s 0.56±0.014 0.66±0.013 0.68±0.009 0.68±0.008 0.75±0.010 <0.001
U2/U1, % 63.7±1.6 68.6±1.6 72.5±1.2 78.3±1.5 80.4±2.1 <0.001
V1, mL 17.5±0.38 17.2±0.34 16.7±0.30 16.3±0.29 15.6±0.42 0.007
V2, mL 52.5±0.88 59.0±0.92 60.8±0.64 59.1±0.61 59.3±1.05 <0.001
V2/V1, % 307.7±4.8 339.3±4.7 372.7±3.7 381.2±4.4 383.4±5.9 <0.001
LVOT Area, cm2 3.00±0.04 3.16±0.03 3.22±0.02 3.16±0.02 3.14±0.04 <0.001
Results are presented as mean±SE. T1 indicates timing of first systolic shoulder of pressure; T2, timing of second systolic shoulder of 
pressure; Tes, timing of end-systolic; Umax, peak of flow velocity; Umean, mean of flow velocity; U1, flow velocity at T1; U2, flow velocity 
at T2; V1, volume at T1; and V2, volume at T2.
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What Is New
•	Age-related change in morphology of the upstroke of the central aortic 
blood pressure waveform in women, augmentation pressure in particu-
lar, is explained by sustained ventricular ejection and increase in stroke 
volume associated with aging and weight gain.
What Is Relevant
•	Conditions and drugs that influence cardiac function may influence pulse 
wave morphology independent of arterial function. Stroke volume is an 
important determinant of central pulse pressure and the increase in cen-
tral pulse pressure can be explained by an increase in stroke volume 
occurring in parallel with that of body mass index. Since drugs with a spe-
cific action to reduce arterial stiffness are not yet available, interventions 
to decrease stroke volume (eg, weight reduction) and modulate ventricu-
lar dynamics might be useful in preventing/treating systolic hypertension.
Summary
Understanding the hemodynamic basis of the age-related increase 
in pulse pressure is key to targeting appropriate treatment strate-
gies to prevent and treat the large burden of cardiovascular disease 
associated with hypertension in middle-aged to older persons. This 
population study in the Twins UK cohort suggests that, in mid-
dle-aged to older women, the age-related increase in central pulse 
pressure results from an increase in aortic stiffness, sustained ven-
tricular ejection, and an increase in stroke volume that parallels 
that in body mass index. The age-related change in morphology 
of the central pressure waveform, in particular, the increase in the 
augmentation pressure, relates to sustained ventricular ejection 
and an altered pattern of ventricular ejection.
Novelty and Significance
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